Iovance Biotherapeutics(IOVA.US) Director Buys US$55,600 in Common Stocks

moomoo News ·  09/20 05:09

$Iovance Biotherapeutics(IOVA.US)$ Director MCPEAK MERRILL A purchased 10,000 shares of Common Stocks on Sep 18, 2023 at an average price of $5.56 for a total value of $55,600.


What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write first comment